Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles

ObjectiveTo compare success rates, associated risks and cost-effectiveness between intrauterine insemination (IUI) and in vitro fertilisation (IVF).DesignRetrospective observational study.SettingThe UK from 2012 to 2016.ParticipantsData from Human Fertilisation and Embryology Authority’s freedom of...

Full description

Bibliographic Details
Main Authors: Judith E Bosmans, Eric Jauniaux, Gulam Bahadur, Roy Homburg, Judith A F Huirne, Peter Hinstridge, Kanna Jayaprakasan, Paul Racich, Rakib Alam, Ioannis Karapanos, Afeeza Illahibuccus, Ansam Al-Habib
Format: Article
Language:English
Published: BMJ Publishing Group 2020-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/3/e034566.full
id doaj-26661ca7040b47189c77e0c4d8f33dc4
record_format Article
spelling doaj-26661ca7040b47189c77e0c4d8f33dc42021-06-02T11:32:10ZengBMJ Publishing GroupBMJ Open2044-60552020-03-0110310.1136/bmjopen-2019-034566Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cyclesJudith E Bosmans0Eric Jauniaux1Gulam Bahadur2Roy Homburg3Judith A F Huirne4Peter Hinstridge5Kanna Jayaprakasan6Paul Racich7Rakib Alam8Ioannis Karapanos9Afeeza Illahibuccus10Ansam Al-Habib113 Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands 7 EGA Institute for Womens Health, Faculty of Population Health Science, University College London, London, WC1E 6HX, UK 1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UK2 Homerton Fertility Unit, Homerton University Hospital, Homerton Row, London E9 6SR, UK4 Research Institute Reproduction and development, University Medical Centers Amsterdam, location VUmc and AMC, De Boelelaan 1081, 1081 HV Amsterdam, The Netherlands 1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UK5 University Hospitals of Derby and Burton NHS Trust, Royal Derby Hospital, Derby, Derby, UK6 Linacre College, Oxford University, St. Cross Road, Oxford, OX13JA, Oxfordshire, UK1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UK1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UK1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UK1 Reproductive Medicine Clinic, North Middlesex University Hospital NHS Trust, London, N18 1QX, UKObjectiveTo compare success rates, associated risks and cost-effectiveness between intrauterine insemination (IUI) and in vitro fertilisation (IVF).DesignRetrospective observational study.SettingThe UK from 2012 to 2016.ParticipantsData from Human Fertilisation and Embryology Authority’s freedom of information request for 2012–2016 for IVF/ICSI (intracytoplasmic sperm injection)and IUI as practiced in 319 105 IVF/ICSI and 30 669 IUI cycles. Direct-cost calculations for maternal and neonatal expenditure per live birth (LB) was constructed using the cost of multiple birth model, with inflation-adjusted Bank of England index-linked data. A second direct-cost analysis evaluating the incremental cost-effective ratio (ICER) was modelled using the 2016 national mean (baseline) IVF and IUI success rates.Outcome measuresLB, risks from IVF and IUI, and costs to gain 1 LB.ResultsThis largest comprehensive analysis integrating success, risks and costs at a national level shows IUI is safer and more cost-effective than IVF treatment.IVF LB/cycle success was significantly better than IUI at 26.96% versus 11.49% (p<0.001) but the IUI success is much closer to IVF at 2.35:1, than previously considered. IVF remains a significant source of multiple gestation pregnancy (MGP) compared with IUI (RR (Relative Risk): 1.45 (1.31 to 1.60), p<0.001) as was the rate of twins (RR: 1.58, p<0.001).In 2016, IVF maternal and neonatal cost was £115 082 017 compared with £2 940 196 for IUI and this MGP-related perinatal cost is absorbed by the National Health Services. At baseline tariffs and success rates IUI was £42 558 cheaper than IVF to deliver 1LB with enhanced benefits with small improvements in IUI. Reliable levels of IVF-related MGP, OHSS (ovarian hyperstimulation syndrome), fetal reductions and terminations are revealed.ConclusionIUI success rates are much closer to IVF than previously reported, more cost-effective in delivering 1 LB, and associated with lower risk of complications for maternal and neonatal complications. It is prudent to offer IUI before IVF nationally.https://bmjopen.bmj.com/content/10/3/e034566.full
collection DOAJ
language English
format Article
sources DOAJ
author Judith E Bosmans
Eric Jauniaux
Gulam Bahadur
Roy Homburg
Judith A F Huirne
Peter Hinstridge
Kanna Jayaprakasan
Paul Racich
Rakib Alam
Ioannis Karapanos
Afeeza Illahibuccus
Ansam Al-Habib
spellingShingle Judith E Bosmans
Eric Jauniaux
Gulam Bahadur
Roy Homburg
Judith A F Huirne
Peter Hinstridge
Kanna Jayaprakasan
Paul Racich
Rakib Alam
Ioannis Karapanos
Afeeza Illahibuccus
Ansam Al-Habib
Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
BMJ Open
author_facet Judith E Bosmans
Eric Jauniaux
Gulam Bahadur
Roy Homburg
Judith A F Huirne
Peter Hinstridge
Kanna Jayaprakasan
Paul Racich
Rakib Alam
Ioannis Karapanos
Afeeza Illahibuccus
Ansam Al-Habib
author_sort Judith E Bosmans
title Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
title_short Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
title_full Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
title_fullStr Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
title_full_unstemmed Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles
title_sort observational retrospective study of uk national success, risks and costs for 319,105 ivf/icsi and 30,669 iui treatment cycles
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2020-03-01
description ObjectiveTo compare success rates, associated risks and cost-effectiveness between intrauterine insemination (IUI) and in vitro fertilisation (IVF).DesignRetrospective observational study.SettingThe UK from 2012 to 2016.ParticipantsData from Human Fertilisation and Embryology Authority’s freedom of information request for 2012–2016 for IVF/ICSI (intracytoplasmic sperm injection)and IUI as practiced in 319 105 IVF/ICSI and 30 669 IUI cycles. Direct-cost calculations for maternal and neonatal expenditure per live birth (LB) was constructed using the cost of multiple birth model, with inflation-adjusted Bank of England index-linked data. A second direct-cost analysis evaluating the incremental cost-effective ratio (ICER) was modelled using the 2016 national mean (baseline) IVF and IUI success rates.Outcome measuresLB, risks from IVF and IUI, and costs to gain 1 LB.ResultsThis largest comprehensive analysis integrating success, risks and costs at a national level shows IUI is safer and more cost-effective than IVF treatment.IVF LB/cycle success was significantly better than IUI at 26.96% versus 11.49% (p<0.001) but the IUI success is much closer to IVF at 2.35:1, than previously considered. IVF remains a significant source of multiple gestation pregnancy (MGP) compared with IUI (RR (Relative Risk): 1.45 (1.31 to 1.60), p<0.001) as was the rate of twins (RR: 1.58, p<0.001).In 2016, IVF maternal and neonatal cost was £115 082 017 compared with £2 940 196 for IUI and this MGP-related perinatal cost is absorbed by the National Health Services. At baseline tariffs and success rates IUI was £42 558 cheaper than IVF to deliver 1LB with enhanced benefits with small improvements in IUI. Reliable levels of IVF-related MGP, OHSS (ovarian hyperstimulation syndrome), fetal reductions and terminations are revealed.ConclusionIUI success rates are much closer to IVF than previously reported, more cost-effective in delivering 1 LB, and associated with lower risk of complications for maternal and neonatal complications. It is prudent to offer IUI before IVF nationally.
url https://bmjopen.bmj.com/content/10/3/e034566.full
work_keys_str_mv AT judithebosmans observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT ericjauniaux observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT gulambahadur observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT royhomburg observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT judithafhuirne observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT peterhinstridge observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT kannajayaprakasan observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT paulracich observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT rakibalam observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT ioanniskarapanos observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT afeezaillahibuccus observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
AT ansamalhabib observationalretrospectivestudyofuknationalsuccessrisksandcostsfor319105ivficsiand30669iuitreatmentcycles
_version_ 1721404707260334080